Ursolic acid in cancer treatment and metastatic chemoprevention: from synthesized derivatives to nanoformulations in preclinical studies.

CONCLUSION: The information presented in this article can provide useful references for further studies on making UA a promising anti-cancer drug, especially as a prophylactic metastatic agent for clinical applications.
PMID: 30332961 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - October 16, 2018 Category: Cancer & Oncology Authors: Zou J, Lin J, Li C, Zhao R, Fan L, Yu J, Shao J Tags: Curr Cancer Drug Targets Source Type: research